X-15250465-T-C

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001031739.3(ASB9):ā€‹c.533A>Gā€‹(p.Gln178Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000145 in 1,209,851 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 63 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00012 ( 0 hom., 5 hem., cov: 23)
Exomes š‘“: 0.00015 ( 0 hom. 58 hem. )

Consequence

ASB9
NM_001031739.3 missense

Scores

2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.91
Variant links:
Genes affected
ASB9 (HGNC:17184): (ankyrin repeat and SOCS box containing 9) This gene encodes a member of the ankyrin repeat and suppressor of cytokine signaling (SOCS) box protein family. Members of this family can interact with the elongin B-C adapter complex via their SOCS box domain and further complex with the cullin and ring box proteins to form E3 ubiquitin ligase complexes. They may function to mediate the substrate-recognition of the E3 ubiquitin ligases. A transcribed pseudogene of this gene has been identified on chromosome 15. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.15058115).
BS2
High Hemizygotes in GnomAd4 at 5 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ASB9NM_001031739.3 linkc.533A>G p.Gln178Arg missense_variant 5/7 ENST00000380488.9 NP_001026909.1 Q96DX5-1A0A024RBW7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ASB9ENST00000380488.9 linkc.533A>G p.Gln178Arg missense_variant 5/71 NM_001031739.3 ENSP00000369855.4 Q96DX5-1

Frequencies

GnomAD3 genomes
AF:
0.000125
AC:
14
AN:
112328
Hom.:
0
Cov.:
23
AF XY:
0.000145
AC XY:
5
AN XY:
34472
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000283
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000188
Gnomad OTH
AF:
0.000664
GnomAD3 exomes
AF:
0.000136
AC:
25
AN:
183184
Hom.:
0
AF XY:
0.000192
AC XY:
13
AN XY:
67628
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000366
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000293
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000147
AC:
161
AN:
1097523
Hom.:
0
Cov.:
30
AF XY:
0.000160
AC XY:
58
AN XY:
362887
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000284
Gnomad4 ASJ exome
AF:
0.0000516
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000182
Gnomad4 OTH exome
AF:
0.000109
GnomAD4 genome
AF:
0.000125
AC:
14
AN:
112328
Hom.:
0
Cov.:
23
AF XY:
0.000145
AC XY:
5
AN XY:
34472
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000283
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000188
Gnomad4 OTH
AF:
0.000664
Alfa
AF:
0.000217
Hom.:
2
Bravo
AF:
0.000181
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.0000988
AC:
12
EpiCase
AF:
0.000164
EpiControl
AF:
0.000237

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 29, 2023The c.533A>G (p.Q178R) alteration is located in exon 5 (coding exon 5) of the ASB9 gene. This alteration results from a A to G substitution at nucleotide position 533, causing the glutamine (Q) at amino acid position 178 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
12
DANN
Uncertain
0.98
DEOGEN2
Benign
0.098
.;.;T;.
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.63
T;.;T;T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.15
T;T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.36
.;N;N;N
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-2.2
N;N;N;N
REVEL
Benign
0.069
Sift
Benign
0.14
T;T;T;T
Sift4G
Benign
0.39
T;T;T;T
Polyphen
0.0080, 0.020
.;B;B;B
Vest4
0.21
MutPred
0.59
.;Gain of MoRF binding (P = 0.1038);Gain of MoRF binding (P = 0.1038);Gain of MoRF binding (P = 0.1038);
MVP
0.64
MPC
0.34
ClinPred
0.033
T
GERP RS
3.3
Varity_R
0.25
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs746850142; hg19: chrX-15268587; API